NCT04356014|Unknown
Loading search results
Sponsor study identifier
observational
14
1 country
1
Study Start
April 1, 2020
Actual (reported)Primary Completion
November 30, 2020
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
December 30, 2020
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Palmoplantar keratoderma (PPK) associated to livid telangiectatic erythema during systemic lupus erythematosus (SLE) and subacute cutaneous lupus erythematosus (SCLE) is a rare phenomenon seldom reported in literature. The investigators hypothesize that clinic-immunologic assessment and detailed investigation of cutaneous biopsy specimen of PPK and erythema of patients suffering from SLE and SCLE could lead to determine more precisely nosological settings of this injury. Report the different therapeutics with efficacy assessment could be helpful to highlight useful treatment for these patients.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 30, 2020
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
April 1, 2020
Actual (reported)April 16, 2020
Actual (reported)April 21, 2020
Actual (reported)November 30, 2020
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
December 30, 2020
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Determine clinic immunologic features
Determine clinic immunologic features of patients with PPK and livid telangiectatic erythema-associated suffering from SLE and SCLE.
1 day
Determine clinic histopathologic features
Epidemiologic clinic immunologic histopathologic data
1 day
Different therapeutics used
1 day
Different therapeutics efficacy assessment
1 day
patients suffering from SLE or SCLE with palmar and or plantar keratoderma with livid telangiectatic erythema
Uh Montpellier
Montpellier, 34295, France
paraffin-embedded and frozen cuteaneous biopsy specimens
Didier BESSIS, PhD
University Hospitals of Montpellier
14 participants (actual enrollment reported by the registry).
First Submitted
April 16, 2020
First Posted
April 21, 2020
Study Start
April 1, 2020
Actual (reported)Role of the Neonatal Fc Receptor for IgG in the Pathophysiology of Lupus
Contact the study team to confirm eligibility.
Primary Completion
November 30, 2020
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
December 30, 2020
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
April 21, 2020
Record last verified: 2020-03
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: